Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-01

Clinical Trial Update: Comparison of Efficacy of Double Dose Oral Terbinafine Vs Itraconazole in Treatment of Dermatophyte Infections of Skin. [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing double-dose oral terbinafine to itraconazole for dermatophyte skin infections has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Itraconazole (Itraconazole)
  • Terbinafine (terbinafine)

Snippet

Sponsor: Pak Emirates Military Hospital | Conditions: Dermatophyte Infection, Terbinafine Adverse Reaction | Phase 3 | Status: COMPLETED